About Matthew
Fortune 100 companies trust Matthew Kent to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.Matthew focuses on bet-the-company antitrust litigation and counseling, with experience in the competition issues at the forefront of the pharmaceutical industry. He has litigated cases in federal courts throughout the country.
Fortune 100 companies trust Matthew Kent to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.Matthew focuses on bet-the-company antitrust litigation and counseling, with experience in the competition issues at the forefront of the pharmaceutical industry. He has litigated cases in federal courts throughout the country.
Fortune 100 companies trust Matthew Kent to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.
Matthew focuses on bet-the-company antitrust litigation and counseling, with experience in the competition issues at the forefront of the pharmaceutical industry. He has litigated cases in federal courts throughout the country.
Fortune 100 companies trust Matthew Kent to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.Matthew focuses on bet-the-company antitrust litigation and counseling, with experience in the competition issues at the forefront of the pharmaceutical industry. He has litigated cases in federal courts throughout the country.
Fortune 100 companies trust Matthew Kent to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.
Matthew focuses on bet-the-company antitrust litigation and counseling, with experience in the competition issues at the forefront of the pharmaceutical industry. He has litigated cases in federal courts throughout the country.
